Recursion Pharmaceuticals' AI-based approach has the potential to transform the pharmaceutical industry. However, it is still chasing clinical wins that would demonstrate the power of its strategy.

A photo is circulating on social media that appears to show President Donald Trump using a walker, but it is AI-generated. The image was originally posted on X by Democratic strategist Keith Edwards, ...

Dec 8 (Reuters) - Recursion Pharma, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths in the colon in ...

When it comes to hard problems, computer scientists seem to be stuck. Consider, for example, the notorious problem of finding the shortest round-trip route that passes through every city on a map ...

Tilray Brands Inc (NASDAQ: TLRY) shares are trading lower in Wednesday’s after-hours session after the company announced a reverse stock split. What To Know: After the market close on Wednesday, ...

A brand new CRIMINAL graphic novel featuring the legendary RICKY LAWLESS and the crazy tale of how he and MALLORY fell in love in the midst of a crime spree. In one of the wildest, most action-packed ...

Investing personality Jim Cramer recently called Recursion Pharmaceuticals a meme stock. The facts don't back up that position, though. Recursion may not be a meme stock, but that doesn't make it a ...

The concept of a meme stock was born about five years ago. It refers to a publicly traded company that gains substantial market value practically overnight (sometimes literally) due to significant ...

Researchers used supramolecular nanoparticles to repair the brain’s vascular system and reverse Alzheimer’s in mice. Instead of carrying drugs, the nanoparticles themselves triggered natural clearance ...

Investors in Recursion (NASDAQ: RXRX) seemed only mildly fazed by Wednesday’s series of company announcements. The artificial intelligence (AI)-based drug developer’s stock barely moved on Wednesday, ...